---
title: Publications
layout: page
---

A full list of publications can be found [here](https://scholar.google.lu/citations?user=JFRauOgAAAAJ&hl=en).

### Key research papers:

- Risk Assessment with Ultra-Low-Pass Whole Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma. Zhao D, Lang N, Liu T, ... Kridel R. JCO Precision Oncology, 2025. 
- Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy. Hershenfeld S, Tobin J, Shelton V, ... Kridel R. British Journal of Haematology, 2024. 
- GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma. He M, Tong K, Liu T, ... Kridel R. Leukemia, 2024. 
- Identification of genetic subtypes in follicular lymphoma. Shelton V, Detroja R, Liu T, â€¦ Kridel R. Blood Cancer Journal, 2024.
-	Combined EZH2 inhibition and Ikaros degradation leads to enhanced anti-tumor activity in diffuse large B-cell lymphoma. Tong K, Yoon S, Isaev K, ... Kridel R. Clinical Cancer Research. 2021.
- A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pre-transplant Deauville score. Yhim HY, Eshet Y, Metser U, Lim CH, ... Kuruvilla J, Kridel R. Blood Advances. 2020 Nov 24;4(22):5762-5771.
- Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma. Calvente L, ... Kridel R. Br J Haematol. Sep;190(6):864-868.
- Molecular Attributes Underlying Central Nervous System and Systemic Relapse in Diffuse Large B-cell Lymphoma. Isaev K, ... Scott DW, Kridel R. Haematologica. 2020 Aug 13;haematol.2020.255950.
- Convergence of risk prediction models in follicular lymphoma. Silva A, ... Kridel R. Haematologica. 2019 Jun;104(6):e252-e255.
- FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab-containing regimens. Mottok A,\* Jurinovic V,\* ... Hoster E,\* Weigert O,\* Kridel R.\* Blood. 2018 Jan 11;131(2):226-235.  (\* denotes equal contribution)
- Diffuse large B-cell lymphoma with testicular involvement: Outcome and risk of CNS relapse in the rituximab era. Kridel R\*, Telio D\*, ... Savage KJ. British Journal of Haematology. 2017 Jan;176(2):210-221. (\* denotes equal contribution)
- Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study. Kridel R\*, Chan FC\*, Mottok A, ... Gascoyne RD, Shah P. PLOS Medicine. 2016 Dec 13;13(12):e1002197. (\* denotes equal contribution)
- Cell of origin of transformed follicular lymphoma. Kridel R,\* Mottok A,\* ... Scott DW, Gascoyne RD. Blood 2015 Oct 29;126(18):2118-27. (\* denotes equal contribution)
- Integration of Gene Mutations Improves Risk Prognostication in Patients Receiving First-line Immunochemotherapy for Follicular Lymphoma in Clinical Trial and Population-Based Cohorts. Pastore A,\* Jurinovic V,\* Kridel R,\* Hoster E,\* ... Gascoyne RD, Weinstock DM, Weigert O. Lancet Oncol. 2015 Sep;16(9):1111-22. (\* denotes equal contribution)
- The prognostic impact of CD163-positive macrophages in follicular lymphoma: A study from the BC Cancer Agency and the LYmphoma Study Association. Kridel R, Xerri L, ... Gascoyne RD, Salles G. Clin Cancer Res. 2015 Aug 1;21(15):3428-35.
- Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Kridel R, Meissner B, ... Weng AP, Steidl C, Gascoyne RD. Plenary Paper. Blood. 2012 Mar 1;119(9):1963-71.

### Key review papers:

- Treatment resistance in diffuse large B-cell lymphoma. He MY, Kridel R. Leukemia. 2021.
- Predicting early progression in follicular lymphoma. Liu Q, Silva A, Kridel R. Annals of Lymphoma. 2021 Jun;5:11.
- Pathogenesis of follicular lymphoma. Lackraj T, Goswami R, Kridel R. Best Practice & Research Clinical Haematology. 2018 Mar;31(1):2-14.
- Can histologic transformation of follicular lymphoma be predicted and prevented? Kridel R, Sehn LH, Gascoyne RD. Blood. 2017 Jul 20;130(3):258-266.
- Pathogenesis of follicular lymphoma. Kridel R, Sehn LH, Gascoyne RD. J Clin Invest. 2012 Oct 1;122(10):3424-31.
- Prevention of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma. Kridel R, Dietrich PY. Lancet Oncol. 2011 Dec;12(13):1258-66.
